Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination-Reference-Cited by-同舟云学术

Induction of cellular and humoral immune responses to tumor cells and peptides in HLA-A24 positive hormone-refractory prostate cancer patients by peptide vaccination

Published:2003-07-23 Issue:1 Volume:57 Page:80-92
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:Prostate

Author:

Noguchi Masanori,Kobayashi Kazuhiko,Suetsugu Norie,Tomiyasu Katsurou,Suekane Shigetaka,Yamada Akira,Itoh Kyogo,Noda Shinshi

Publisher

Wiley

Subject

Urology,Oncology

Reference35 articles.

1. A reevaluation of nonhormonal cytotoxic chemotherapy in the treatment of prostatic carcinoma.

2. Systemic treatment for prostate cancer

3. A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

4. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes.

5. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by geneMAGE-3 and presented by HLA-A1

Cited by 96 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of Personalized Dendritic Cell-Based Immunohybridoma Vaccines to Treat Prostate Cancer;Life;2023-07-01

2. The safety and efficacy of CAR-T cells in the treatment of prostate cancer: review;Biomarkers;2021-12-20

3. A COVID-19 peptide vaccine for the induction of SARS-CoV-2 T cell immunity;Nature;2021-11-23

4. Application of Urinary Volatile Organic Compounds (VOCs) for the Diagnosis of Prostate Cancer;Clinical Genitourinary Cancer;2019-06

5. Immunotherapy for CRPC;Management of Advanced Prostate Cancer;2018